205 related articles for article (PubMed ID: 32318709)
1. Post-translational modifications and stress adaptation: the paradigm of FKBP51.
Rein T
Biochem Soc Trans; 2020 Apr; 48(2):441-449. PubMed ID: 32318709
[TBL] [Abstract][Full Text] [Related]
2. FKBP51 plays an essential role in Akt ubiquitination that requires Hsp90 and PHLPP.
Tufano M; Marrone L; D'Ambrosio C; Di Giacomo V; Urzini S; Xiao Y; Matuozzo M; Scaloni A; Romano MF; Romano S
Cell Death Dis; 2023 Feb; 14(2):116. PubMed ID: 36781840
[TBL] [Abstract][Full Text] [Related]
3. USP49 negatively regulates tumorigenesis and chemoresistance through FKBP51-AKT signaling.
Luo K; Li Y; Yin Y; Li L; Wu C; Chen Y; Nowsheen S; Hu Q; Zhang L; Lou Z; Yuan J
EMBO J; 2017 May; 36(10):1434-1446. PubMed ID: 28363942
[TBL] [Abstract][Full Text] [Related]
4. InterAKTions with FKBPs--mutational and pharmacological exploration.
Fabian AK; März A; Neimanis S; Biondi RM; Kozany C; Hausch F
PLoS One; 2013; 8(2):e57508. PubMed ID: 23469007
[TBL] [Abstract][Full Text] [Related]
5. The nonreceptor tyrosine kinase SRMS inhibits autophagy and promotes tumor growth by phosphorylating the scaffolding protein FKBP51.
Park JM; Yang SW; Zhuang W; Bera AK; Liu Y; Gurbani D; von Hoyningen-Huene SJ; Sakurada SM; Gan H; Pruett-Miller SM; Westover KD; Potts MB
PLoS Biol; 2021 Jun; 19(6):e3001281. PubMed ID: 34077419
[TBL] [Abstract][Full Text] [Related]
6. LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex.
Shang Z; Yu J; Sun L; Tian J; Zhu S; Zhang B; Dong Q; Jiang N; Flores-Morales A; Chang C; Niu Y
Nucleic Acids Res; 2019 May; 47(8):4211-4225. PubMed ID: 30773595
[TBL] [Abstract][Full Text] [Related]
7. Pink1 regulates FKBP5 interaction with AKT/PHLPP and protects neurons from neurotoxin stress induced by MPP
Boonying W; Joselin A; Huang E; Qu D; Safarpour F; Iyirhiaro GO; Gonzalez YR; Callaghan SM; Slack RS; Figeys D; Chung YH; Park DS
J Neurochem; 2019 Aug; 150(3):312-329. PubMed ID: 30734931
[TBL] [Abstract][Full Text] [Related]
8. FKBP51 regulation of AKT/protein kinase B phosphorylation.
Wang L
Curr Opin Pharmacol; 2011 Aug; 11(4):360-4. PubMed ID: 21498116
[TBL] [Abstract][Full Text] [Related]
9. Assembly of the FKBP51-PHLPP2-AKT signaling complex in cerebral ischemia/reperfusion injury in rats.
Wei XE; Zhang FY; Wang K; Zhang QX; Rong LQ
Brain Res; 2014 May; 1566():60-8. PubMed ID: 24746496
[TBL] [Abstract][Full Text] [Related]
10. FKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications.
Gassen NC; Hartmann J; Zannas AS; Kretzschmar A; Zschocke J; Maccarrone G; Hafner K; Zellner A; Kollmannsberger LK; Wagner KV; Mehta D; Kloiber S; Turck CW; Lucae S; Chrousos GP; Holsboer F; Binder EB; Ising M; Schmidt MV; Rein T
Mol Psychiatry; 2016 Feb; 21(2):277-89. PubMed ID: 25849320
[TBL] [Abstract][Full Text] [Related]
11. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt.
Pei H; Li L; Fridley BL; Jenkins GD; Kalari KR; Lingle W; Petersen G; Lou Z; Wang L
Cancer Cell; 2009 Sep; 16(3):259-66. PubMed ID: 19732725
[TBL] [Abstract][Full Text] [Related]
12. A molecular link between AKT regulation and chemotherapeutic response.
Dibble CC; Manning BD
Cancer Cell; 2009 Sep; 16(3):178-80. PubMed ID: 19732717
[TBL] [Abstract][Full Text] [Related]
13. The Many Faces of FKBP51.
Hähle A; Merz S; Meyners C; Hausch F
Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30669684
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
[TBL] [Abstract][Full Text] [Related]
15. Regulation of FKBP51 and FKBP52 functions by post-translational modifications.
Daneri-Becerra C; Zgajnar NR; Lotufo CM; Ramos Hryb AB; Piwien-Pilipuk G; Galigniana MD
Biochem Soc Trans; 2019 Dec; 47(6):1815-1831. PubMed ID: 31754722
[TBL] [Abstract][Full Text] [Related]
16. The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2.
Jamal A; Swarnalatha M; Sultana S; Joshi P; Panda SK; Kumar V
Cell Cycle; 2015; 14(16):2688-700. PubMed ID: 26038816
[TBL] [Abstract][Full Text] [Related]
17. Calcium- and FK506-independent interaction between the immunophilin FKBP51 and calcineurin.
Li TK; Baksh S; Cristillo AD; Bierer BE
J Cell Biochem; 2002; 84(3):460-71. PubMed ID: 11813252
[TBL] [Abstract][Full Text] [Related]
18. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes.
Ugi S; Imamura T; Maegawa H; Egawa K; Yoshizaki T; Shi K; Obata T; Ebina Y; Kashiwagi A; Olefsky JM
Mol Cell Biol; 2004 Oct; 24(19):8778-89. PubMed ID: 15367694
[TBL] [Abstract][Full Text] [Related]
19. FK506 binding protein 51 integrates pathways of adaptation: FKBP51 shapes the reactivity to environmental change.
Rein T
Bioessays; 2016 Sep; 38(9):894-902. PubMed ID: 27374865
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C-mediated down-regulation of cyclin D1 involves activation of the translational repressor 4E-BP1 via a phosphoinositide 3-kinase/Akt-independent, protein phosphatase 2A-dependent mechanism in intestinal epithelial cells.
Guan L; Song K; Pysz MA; Curry KJ; Hizli AA; Danielpour D; Black AR; Black JD
J Biol Chem; 2007 May; 282(19):14213-25. PubMed ID: 17360714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
